Inhibition of Pro-inflammatory Processes Reduces Sensitization of the Behavioral Response to Maternal Separation by Paik, Kristopher Doojin
Wright State University 
CORE Scholar 
Browse all Theses and Dissertations Theses and Dissertations 
2009 
Inhibition of Pro-inflammatory Processes Reduces Sensitization 
of the Behavioral Response to Maternal Separation 
Kristopher Doojin Paik 
Wright State University 
Follow this and additional works at: https://corescholar.libraries.wright.edu/etd_all 
 Part of the Anatomy Commons 
Repository Citation 
Paik, Kristopher Doojin, "Inhibition of Pro-inflammatory Processes Reduces Sensitization of the Behavioral 
Response to Maternal Separation" (2009). Browse all Theses and Dissertations. 958. 
https://corescholar.libraries.wright.edu/etd_all/958 
This Thesis is brought to you for free and open access by the Theses and Dissertations at CORE Scholar. It has 
been accepted for inclusion in Browse all Theses and Dissertations by an authorized administrator of CORE 






INHIBITION OF PRO-INFLAMMATORY PROCESSES REDUCES SENSITIZATION 











A thesis submitted in partial fulfillment 
of the requirements for the degree of 








KRISTOPHER DOOJIN PAIK 























WRIGHT STATE UNIVERSITY 
 
SCHOOL OF GRADUATE STUDIES 
 
  September 17, 2009 
 
I HEREBY RECOMMEND THAT THE THESIS PREPARED UNDER MY 
SUPERVISION BY Kristopher Doojin Paik ENTITLED 
Inhibition of Pro-inflammatory Processes Reduces 
Sensitization of the Behavioral Response to Maternal 
Separation BE ACCEPTED IN PARTIAL FULFILLMENT OF THE 











































Paik, Kristopher Doojin.  M.S., Anatomy Program, Department of 
Neuroscience, Cell Biology, and Physiology, Wright State 
University, 2009.  Inhibition of pro-inflammatory processes 





The current study examined the behavioral sensitization of guinea pig pups in response to 
consecutive days of maternal separation. In the first experiment, guinea pigs that received 
centrally administered artificial cerebrospinal fluid or IL-10 exhibited sensitization of 
passive behaviors from Day 1 to Day 2. IL-10 decreased the levels of passive behaviors 
on Day 1, as well as the increase on Day 2. The second experiment used unoperated pups, 
which also showed sensitization of the passive response from Day 1 to Day 2, though the 
effect appeared reduced relative to control pups of Experiment 1. Collectively, this 
investigation confirms previous evidence that passive behaviors are due in part to pro-
inflammatory cytokines. It also provides evidence that the increase in passive measures 
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Sickness Behavior and Pro-inflammatory cytokines 
When macrophages and monocytes encounter a foreign antigen, they secrete 
numerous cytokines as an initial line of defense against disease. These cytokines are large 
glycoproteins (8-40,000 d.) that facilitate cell-cell communication, growth, 
differentiation, white blood cell recruitment, and lymphocyte turnover, and often serve as 
anti-viral agents (Hopkins, 2003; Whiteside, 2007). Currently, scientists have identified 
scores of cytokines and their unique roles during progression of a disease. Cytokines can 
be classified as being either pro-inflammatory, such as Interleukin-1 (IL-1), IL-6 and 
tumor necrosis factor-α (TNF-α), or anti-inflammatory, such as IL-4, IL-10, and IL-13 
(Dinarello, 2000).  The cytokines that are considered pro-inflammatory promote a 
cascade of events that precede inflammation, and those that are anti-inflammatory inhibit 
pro-inflammatory cytokines and down regulate their genetic expression (Dinarello, 
2000). 
There is a large body of evidence supporting the relationship between immune 
challenge and cytokine release. In numerous studies, investigators have successfully 
induced pro-inflammatory cytokine production through administration of bacterial 
endotoxin (lipopolysaccharide or LPS) in rodent models. LPS is a necessary component 
of all viable gram-negative bacteria and has been found to elicit the innate immune 
response, including pro-inflammatory cytokine release. For instance, an early study by 
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Zuckerman, Shellhaas, and Butler (1989) reported that intraperitoneal injections of LPS 
in mice rapidly increased circulating levels of TNF-α and IL-1 in the blood. Recently, it 
was found that peripheral and central injections of LPS increased levels of IL-6 secreted 
by glial cells (Beurel & Jope, 2009). These studies, in addition to many others in the 
literature, provide indisputable evidence of pro-inflammatory cytokine production during 
a non-specific immune reaction.  
It is well documented that during infection from invading microorganisms and 
tissue damage, pro-inflammatory cytokines coordinate homeostatic and physiological 
mechanisms to diminish the virulence of pathogens. The physical changes in the body 
associated with illness constitute what is known as the acute phase response (APR) 
characterized by fever, hyperalgesia, changes in liver proteins (C-reactive protein, 
fibrinogen, alpha2-macroglobulin), malaise, and reduced appetite (Baumann & Gauldie, 
1994; Moshage, 1997). With these physical symptoms, however, exists an element of 
behavioral change, termed “sickness behavior”, that is also believed to be a defense 
mechanism to protect the body during a weakened state (Hart, 1988; Kent, Bluthe, Kelley 
& Dantzer, 1992). Some of these responses appear to be motivated behaviors. For 
instance, there is shivering or seeking of warmth to promote increased body temperature, 
anhedonia (lack of interest in pleasure), and reduced goal oriented activity such as 
lethargy, exploration, and socio-sexual interaction to conserve energy or to reduce the 
spread of pathogens  (Hart, 1988). It is hypothesized that these behaviors are adaptive to 
nullify the detrimental effects of a pathogen. In addition, there are also cognitive deficits 
or reduced learning that can manifest during sickness.    
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Research in the past few decades has highlighted the effects pro-inflammatory 
cytokines on the central nervous system, which can help account for the behaviors 
observed during sickness. The mere fact that an immune challenge can alter the 
behavioral aspect of the acute phase response suggests that pro-inflammatory cytokines 
involved in mediating a peripheral response (e.g. inflammation) also modify central 
neural activity (Dantzer, 2001).  
 
Pathway of Cytokines to the CNS  
 The interplay between pro-inflammatory cytokines and the central nervous system 
is fairly complex because of the existence of the blood-brain barrier (BBB). This barrier 
is maintained by tight junctional complexes of endothelial cells, consequently 
discouraging the passage of numerous substances such as large molecules and drugs 
(Gartner & Hiatt 2007). Cytokines are highly unlikely to pass through the BBB because 
of their size and hydrophilic nature (Blatteis, 2000). Knowing this, investigators have 
tried to identify how peripherally released cytokines influence central activity. There are 
at least two general mechanisms to help explain how peripheral cytokines reach targets in 
the central nervous system.   
 The first possibility is that pro-inflammatory cytokines travel to the brain via a 
humoral pathway. If cytokines were to cross the BBB, they might do so at regions of the 
brain where the BBB is weak or deficient (Banks, Kastin & Broadwell, 1995; Dunn, 
2006; Maier & Watkins, 1998). These areas of the brain consist of the circumventricular 
organs (CVO’s), which include the subfornical organ, pineal gland, median eminence, 
organum vasculosum laminae terminalis, and the area postrema (Dunn, 2006). Once 
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cytokines pass this barrier, they would be able to bind to receptors on neural tissue, for 
example, the hippocampus, and act locally.  
 There is also evidence suggesting that peripheral cytokines may stimulate cells of 
the brain’s parenchyma to produce pro-inflammatory cytokines themselves (Dantzer, 
2004). Van Dam, Brouns, Louisse, and Berkenbosch (1992) discovered possible sources 
of IL-1β from macrophages of the meninges and choroid plexus, microglial cells, and 
perivascular cells. These locally produced cytokines can then volume diffuse to neuronal 
targets. In addition to diffusion, there is reasonable evidence suggesting an active 
transport system exists for cytokines trying to enter the brain. Using radioiodinated 
murine IL-1α and IL-1β, one study found that the rate at which the murine interleukins 
crossed the BBB exceeded the rate at which radioidoinated albumin crossed by 
approximately 50 times (Banks & Kastin, 1991). Transport of IL-1α and IL-1β was also 
found to be self-inhibiting, suggesting that a transport system exists, but also that it is a 
saturable, carrier-mediated transport.    
 The second possible way cytokines may signal the brain is neurally. Systemic 
pro-inflammatory cytokines can bind directly to afferent nerve fibers that innervate 
organs of the immune system. IL-1 receptors have been located on chemoreceptor-like 
structures called paraganglia surrounding vagus nerve terminals (Maier & Watkins, 
1998). Once pro-inflammatory cytokines bind, paraganglia synapse and release 
neurotransmitters on the vagus nerve thereby stimulating it. Vagal nerve fibers terminate 
on the nucleus tractus solitarius of the medulla from which axons then project to areas of 
the brain related to mood and stress, such as the paraventricular nucleus of the 
hypothalamus, central nucleus of the amygdala, and the bed nucleus of the stria 
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terminalis (Ericsson, Kovacs & Sawchenko, 1994; O’Keane, Dinana, Scott & Corcoran, 
2005). Experiments providing compelling evidence for the role of the vagus nerve found 
that peripheral injections of IL-1β activated the marker c-fos in the vagus nerve, and that 
cutting the vagus below the diaphragm inhibited fever and sickness behavior induced by 
administration of a pro-inflammatory cytokine (Goehler et al., 1999; Watkins et al., 1995; 
Bluthe, 1996). 
 
Cytokines and Stress 
 Accruing evidence demonstrates that there is an intimate connection between 
stress and cytokines. Certain stressors can trigger the release of pro-inflammatory 
cytokines, which subsequently produce behaviors characteristic of an acute phase 
response. Physical stressors such as tail shock appeared to activate elements of the APR 
including increased core body temperature (fever), and elevated serum levels of the pro-
inflammatory cytokines IL-1β and IL-6 (Maier & Watkins, 1998; Zhou, Kusnecov, 
Shurin, DePaoli & Rabin, 1993; Nguyen et al., 1998). Immobilizing and restraining of 
rats coupled with insulin-induced hypoglycemia increased levels of IL-1 expression in 
the hypothalamus (Deak et al., 2005).  Even exposure to a novel environment, a 
psychological stressor, induced production of IL-1β (LeMay, Vander & Kluger, 1990).  
 Furthermore, the presence of pro-inflammatory cytokines activates the 
hypothalamic-pituitary-adrenal (HPA) axis, a defining characteristic of stress. 
Besedovsky, del Rey, Sorkin, and Dinarello (1986) were the first to establish the role of 
cytokines in the activity of the HPA axis in rats. Levels of adrenocorticotropin hormone 
(ACTH) and corticosterone (the principal glucocorticoid of rats) in serum increased 
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rapidly following small doses of IL-1 delivered intraperitoneally. ACTH is an 
endogenous secretion of the anterior pituitary that signals the adrenal cortex to release 
glucocorticoids. These glucocorticoids have a plethora of effects including suppression of 
inflammatory activity, and increased metabolism of carbohydrates. Clearly, cytokines in 
this manner can influence behavioral and endocrine responses to stressors.  
 
Maternal Separation as a Stressor 
 Certain early experiences during critical periods of development can influence the 
susceptibility of the organism to stress, illness, and mood disorders (Ader & Friedman, 
1965).  For instance, in rodent species, brief separation from the mother, often combined 
with responses to novelty, affects behavior and physiology well into adulthood (Kohman, 
Tarr, Day, McLinden & Boehm, 2008). A recent study provides evidence that maternal 
separation during infancy impacts the ability of an adult mouse to cope with immune 
challenges. Avitsur and Sheridan (2009) reported that pups that were separated from their 
mothers during the pre-weaning period exhibited more sickness behaviors as adults 
(anorexia and reduced sucrose intake) after injections of LPS or influenza virus than pups 
that were not separated from their mothers. In this scenario, neonatal stress appeared to 
enhance the sensitivity of the pup’s immune system. 
 Spitz (1946) was among the first to thoroughly analyze behavioral changes due to 
the stress of maternal separation and novel environment. Particularly, Spitz extensively 
studied the effects of prolonged maternal separation in hospitalized, quarantined children. 
These children had little to no contact with their primary caregivers for days and even 
weeks at a time. As a result, a subset of children became socially withdrawn, inactive, 
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and generally appeared to be sick. In time, Spitz would introduce the term “anaclitic 
depression” as a diagnosis for these children. Continuing research concerning maternal 
separation used nonhuman primate models in the 1960’s to help define current principles 
of attachment and separation. Following separation there initially is a “protest” stage in 
which young vocalize and actively search for maternal contact; and, after some time, a 
“despair stage” in which a percentage of the infants will display depressive-like behaviors 
such as apathy, withdrawal, and unresponsiveness to stimuli (Kaufman & Rosenblum, 
1967). In further investigations, biochemical analysis of isolated monkey infants revealed 
clear indication of stress during separation. HPA activity increased, and there were 
excessive levels of tyrosine hydroxylase, phenylethanolamine-n-methyl transferase, and 
choline acetylase in the adrenal gland, as well as increases in concentrations of tyrosine 
hydroxylase and choline acetylase in the sympathetic chain ganglion (Mineka & Suomi, 
1978). Thus, the despair stage appeared associated with activation of both the HPA and 
sympathetic nervous system in the course of stress response. 
    
Maternal Separation in Guinea Pigs  
 Guinea pigs will be used as a model in this investigation for studying the 
psychobiological response to maternal separation. Unlike other common laboratory 
rodents, guinea pig pups possess evidence of a strong filial attachment. They are born 
fully furred, with eyes and ears open, allowing them to locomote on the day of birth. In 
addition, pups are able to eat solid food and drink water within a few days of birth 
(Hennessy, 2003). In contrast to many rodents, the mother is unusually passive; therefore, 
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the pup has a strong attraction to the mother that serves to maintain mother-pup 
proximity. 
 Research has documented similarities in the response of guinea pigs and of infant 
primates during brief maternal separation (Carter & Marr, 1970; Hennessy, 2003). When 
placed in a novel environment alone, guinea pig pups will exhibit “active” and “passive” 
behaviors, suggestive of the “protest” and “despair” stages of primate separation 
(Hennessy & Morris, 2005). Immediately following isolation, a guinea pig pup will begin 
to display the active behaviors of vocalizing and locomotor activity. After some time, the 
pup will no longer display active behaviors, but will exhibit passive behaviors, notably 
prolonged eye closure, a characteristic crouched stance, and extensive piloerection 
(Figure 1). Previous studies with infant guinea pigs suggest these passive behaviors are 
mediated centrally by pro-inflammatory cytokines (i.e are sickness behaviors). 
Administration of several anti-inflammatory agents attenuated passive behaviors induced 
by protracted maternal separation. For instance, α-MSH, an endogenous neuropeptide 
with numerous anti-inflammatory properties, reduced incidence of eye-close, crouch, and 
piloerection in maternally isolated pups (Schiml-Webb, Deak, Greenlee, Maken & 
Hennessy, 2006). Additionally, indomethacin, a prostaglandin synthesis inhibitor, 
reduced passive behaviors observed during separation (Hennessy, Schiml-Webb, Miller, 
Maken, Bullinger & Deak, 2007). These results indicate that depressive-like behaviors 
following maternal separation may be sickness behaviors mediated by pro-inflammatory 












Figure 1. A guinea pig pup displaying sickness behaviors of eye-closure, characteristic crouched posture, 










IL-10 as an anti-inflammatory agent     
 In the present study, IL-10, a potent anti-inflammatory agent, was used to inhibit 
pro-inflammatory influences on behavior. IL-10 was originally discovered in 1989 as a  
cytokine synthesis inhibitory factor that blocked cytokine production from type 1  
T-helper cells. Although all important producers of IL-10 are unknown, sources of IL-10 
include B cells, dendritic cells, macrophages, monocytes, type 2 T-helper cells, type 1 
regulatory T cells, subsets of regulatory T-cells (Tr1, Th1, Th17, CD4+, and CD8+), 
keratinocytes, and epithelial cells (Moore, de Waal Malefyt, Coffman & O’Garra, 2001). 
It appears that antigenic stimulation causes the production of IL-10, most notably in 
antigen presenting cells (APC) such as macrophages and dendritic cells (Howard & 
O’Garra, 1992).  
 IL-10 has an immense array of biological properties that can both suppress and 
costimulate numerous types of cells. If IL-10 is present, macrophages/monocytes and 
CD4+ cells will decrease production of various pro-inflammatory cytokines including IL-
1α, IL-1β, IL-2, IL-5, IL-6, IL-12, interferon-α (IFN-α), as well as multiple stimulating 
factors. Antigen presenting capabilities of macrophages are impeded from down 
regulation of major histocompatibility complex class II proteins, and costimulatory 
molecules such as CD54 and CD80. IL-10 also inhibits the differentiation and maturation 
of dendritic cells from monocyte precursors. On the other hand, stimulatory actions of IL-
10 include promoting the proliferation/cytoxicity of CD8+ cells, and activating natural 
killer cells. Finally, B-cell activity is enhanced for prolonged antibody production (de 
Waal Malefyt, 1998).  
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 IL-10 has also been found to modulate endocrine stress responses. Accordingly, 
investigators have focused on the activity of cells derived from the hypothalamus, 
pituitary gland, and adrenal gland. Data from such experiments attest that in murine 
models, IL-10 not only is produced by cells of these glands, but actually enhances 
hormonal secretions by them (Hughes, Cadet, Rady, Tyring, Chin & Smith, 1994; Rady, 
Smith, Cadet, Opp, Tyring & Hughes, 1995; Smith, Cadet, Stefano, Opp & Hughes, 
1999). For instance, IL-10 caused ACTH production in pituitary and spleen cells, and 
also up regulated levels of corticotropin-releasing factor (CRF) from the hypothalamus. 
With DNA microarray technology, researchers were also able to confirm that cells of the 
hypothalamus, pituitary gland, and adrenal gland modified gene expression when treated 
with IL-10 (Tu et al., 2007). That is, it was possible to detect alterations in mRNA 
expression of specific genes in cells of the HPA axis in the presence of IL-10.   
 IL-10 can also reduce sickness behaviors that are produced in response to 
cytokines or stressors. For example, in experiments in which rodents received peripheral 
or central injections of LPS, IL-10 was found to counteract the depressive behavioral 
changes following administration of LPS. Bluthe et al. (1999) reported that lateral 
ventricle delivery of IL-10 successfully restored body weight, exploration, and mobility 
in rats 3 hours after LPS infusion. In addition, IL-10 knockout mice were found to be less 
competent in a hippocampus-dependent learning and memory task (Morris water maze) 
than control mice following a peripheral dose of LPS (Richwine, Sparkman, Dilger, 
Buchanan & Johnson, 2009). Further, Mesquita et al. (2008) also found that 
administration of IL-10 reversed depressive-like behaviors displayed in IL-10 knockout 
mice during a forced swimming test. There was a significant increase in swimming 
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activity instead of immobile helplessness as seen in IL-10 knockout females. Finally, a 
recent study in our lab reported that centrally delivered IL-10 reduced the passive 
behaviors of guinea pigs pups during protracted maternal separation (Perkeybile, Schiml-
Webb, O’Brien, Deak & Hennessy, 2009). These data suggest that IL-10 is a potent 
antagonist to pro-inflammatory mediated behaviors. 
  
Depression and Cytokines 
Not long ago, researchers began to consider the relation of sickness behaviors to 
depressive illness. Indeed, there are overriding similarities between the behavioral 
patterns observed during sickness and the behaviors of depression. During sickness, there 
often is loss of ability to experience pleasure, chronic fatigue, hypomotility, cognitive 
deficits, and weight loss. Interestingly, clinicians include these same symptoms, 
according to the Diagnostic and Statistical Manual (DSM-IV-R), as part of the criteria to 
diagnose patients with depression. Thus, it has been suggested that pro-inflammatory 
cytokines may be a major contributor to depressive disorders. Substantial clinical 
evidence includes higher levels of cytokines in depressed patients compared to control 
subjects. For example, levels of IL-1β and IL-6 (when detected), increased significantly 
in patients diagnosed with major depression (Anisman, Ravindran, Griffiths & Merali, 
1999; Thomas, Davis, Morris, Jackson, Harrison & O’Brien, 2005; Berk, Wadee, 
Kuschke & O’Neill-Kerr, 1997; Maes, 1995). Moreover, therapeutic administration of 
IL-2 and IFN-α for cancer and Hepatitis C produced “sickness behaviors”, such as 
sluggishness, fatigue, depressed mood, and social withdrawal (Bonaccorso, Marino, 
Biondi, Grimaldi, Ippoliti & Maes, 2002; Capuron et al., 2001). IL-2 and IFN-α are 
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cytokines used for their antiviral and antitumor properties of stimulating lymphocyte 
activity that can have pro-inflammatory effects. These findings raise the possibility that 
part of the mechanism by which maternal separation might lead to depression is by 
inducing a pro-inflammatory reaction.  
It is now well established that early maternal separation and other forms of 
attachment disruption (e.g. abuse, neglect) increases the odd of developing depression in 
later life (Heim, Newport, Mletzko, Miller & Nemeroff, 2008). If early separation or 
other early stressors increase the risk of later depression, perhaps this is due in part to a 
sensitization of the cytokine response to stressors so that later exposure to stressors 
produces a greater cytokine mediated depressive response. There is some evidence 
supporting this possibility.  
Several publications have reported the effects of cytokine re-exposure on 
increased HPA activity. Rats that were pretreated with a single dose of IL-1β, and later 
given an additional dose of IL-1β, increased production, storage, and secretion of 
arginine vasopressin (AVP) and CRF in secretory terminals of the external zone of the 
median eminence (Schmidt, Janszen, Wouterlood & Tilders, 1995). AVP is a 
neuropeptide that augments ACTH responsiveness to CRF in the pituitary gland. Pre-
treatment with IL-1β also increased ACTH and corticosterone levels after foot shock 
compared to rats pre-treated with saline (Schmidt, Janszen, Wouterlood & Tilders, 1995). 
Importantly, this study shows there is hyperactivity in the HPA response, a putative 
contributor to depressive illness, to repeated cytokine exposure, and suggests that there 
may even be a long-lasting effect of pro-inflammatory cytokines.  
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In another related study, Hayley, Brebner, Lacosta, Merali & Anisman (1999) 
investigated the sensitizing effects repeated exposure to TNF-α, a pro-inflammatory 
cytokine, can have on the HPA response and sickness behaviors. After mice received an 
initial administration of TNF-α, subsequent re-exposure 14-28 days later produced an 
increase in sickness behaviors compared to mice that received pre-treatment and re-
exposure to saline. The sickness behaviors included decreased food intake, decreased 
consumption of palatable substances (chocolate milk), immobility, curled posture, and 
reduced exploration. In addition, there was an increase in plasma corticosterone. These 
findings clearly suggest that the response to repeated stimulation can, in at least some 
circumstances, produce a greater cytokine mediated depressive response.   
Recently, our laboratory reported behavior sensitization in guinea pigs pups that 
were maternally separated for two consecutive days. There was an unexpected 4-fold 
increase in passive behaviors of pups on the second day of separation (Hennessy et al., 
2008). We hypothesized that this augmented passive response might be due to 
sensitization of pro-inflammatory processes during maternal separation. The present 
study was designed to test this hypothesis.       
 
Integration and Predictions 
 In the first experiment, animals received central infusion of an anti-inflammatory 
agent (IL-10) or control vehicle prior to an initial three-hour separation. Pups were 
separated in a similar way on the second day. If the pro-inflammatory response on Day 1 
contributes to sensitization of the passive response, then we predicted blocking pro-
inflammatory processes with IL-10 would reduce the sensitization process.  
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 Behavior sensitization has only been seen in pups that underwent surgery. That is, 
in the Hennessy et al. (2008) study, pups had received surgery several days earlier to 
implant a telemetry probe to measure body temperature. Therefore, the next experiment 
examined behavior sensitization in pups that did not receive surgery. Unoperated pups 






























Male and female albino guinea pigs (Cavia porcellus) of the Hartley strain were 
bred in our laboratory.  Each remained with the mother and littermates in polycarbonate 
cages (75cm x 54cm x 24cm) throughout the duration of the study, except for brief 
periods for placement of cannulae, routine laboratory management procedures (such as 
weighing), and behavioral testing. Each cage was filled with sawdust bedding, and guinea 
pig food and water were available ad libitum. The testing and colony rooms were both 
maintained between 65 and 70˚ F. The lights in the colony room operated on a 12-hour 
light/dark cycle with lights on at 7 am and off at 7 pm. The Wright State University 
Laboratory Animal Care and Use Committee approved all procedures prior to 
experimentation.   
 
Behavior Test Procedures 
 The first behavior test occurred between Days 21-23 postnatal, while the second 
behavior test was conducted on the following day. Figure 2 represents a timeline of 
events for each subject.  
 
 

























Pups were exposed to the novel environment for 3 hours between 8:30 am and 12:00 pm. 
An observer scored behaviors at the following intervals: 0-30 minutes, 60-90 minutes, 
and 150-180 minutes. To begin the test, a pup was quietly transferred to an adjacent room 
and placed in a clear, plastic cage (47cm x 24cm x 20cm) with a vented lid. The testing 
room was maintained between 65-70°F, and adjusted with space heaters as necessary.  
 
Behavior Scoring 
    
 A trained observer scored active and passive behaviors behind a one-way glass. 
Active behaviors included vocalizations (high pitched “whistles”) and line-crossings (all 
four feet of the pup cross any one of four lines that equally divides the cage; Berryman, 
1976). Passive behaviors included eye-close (near or complete closure of one or both 
eyes for at least one second), crouch (body hunched over, head tucked in between 
shoulders, and feet tucked beneath body), and piloerection (hair standing up over 
majority of the body surface). Passive behaviors, which tend to occur over protracted 
periods, were scored in a one-zero fashion each minute. It is important to note that the 
term “full passive” is used when all three passive behaviors occurred in the same minute 
interval.  All occurrences of active behaviors (vocalizations and line crossings) were 
scored. A microphone set up above the test cage broadcasted vocalizations to an observer 
wearing headphones, who counted them with a hand counter. Line-crossings were tallied 





Data Analyses  
For passive behaviors, the number of 60-s intervals in which the pup displayed a 
particular behavior was analyzed, as well as the number of 60-s intervals of the “full 
passive” response. Because of non-normal distributions, non-parametric tests were 
conducted to analyze passive behaviors. These were Mann-Whitney U tests for between-
group comparisons, and Wilcoxon signed-ranks tests for within-group comparisons.  
Because the data for active behaviors in Experiment 1 were normally distributed, 
vocalization and line-crossings were examined with analyses of variance (ANOVAs). In 
Experiment 2, heterogeneity of variances was significant for vocalization (p<0.01; 
Levene’s Test). Therefore, non-parametrics were used for active behaviors in Experiment 
2. The level of significance was set at p<.05 (2-tailed). 
For passive measures, central tendency and variability were expressed as medians 
and semi-interquartile ranges when non-parametrics were used. Central tendency and 





























 Experimental Conditions. Twenty-three pups were randomly assigned to two 
experimental conditions. No more than one pup per litter was assigned to either 
condition. In the aCSF condition, 6 females and 5 males were tested, while the IL-10 
condition included 6 females and 6 males. Each pup was tested twice with either 5 μl of 
aCSF, or 50 ng of IL-10 dissolved in 5 μl aCSF, given centrally on the first day only. 
This dose of IL-10 was chosen because it was the median effective dose that previously 
reduced passive behaviors in isolated guinea pigs (Perkeybile et al., 2009).  
 
 
ICV Surgery. Between Days 16-19, pups underwent aseptic intracerebral 
ventricular (ICV) surgery for placement of an indwelling cannula targeting the lateral 
ventricle. Following pretreatment with atropine (.05 mg/kg, intraperitoneal), pups were 
anesthetized with 3-5% isoflurane. A local analgesic (0.25mg/0.1ml 0.25% bupivicaine) 
was administered subcutaneously to the scalp before the first incision. Using a stereotaxic 
device, guide cannulae (26 gauge) were implanted relative to bregma at -3.0 mm  
anterior-posterior, -3.0 mm medial-lateral, and -4.0 mm dorsal-ventral. Adjacent to the 
cannula’s entry, a stainless steel metal screw was embedded in the calvaria to help anchor 
the cranioplastic cement.  All surgical equipment was sterile prior to use. Cannulation 
supplies were purchased from Plastics One  (Roanoke, VA). Post-operatively, pups were 
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given intraperitoneal injections of buprenorphine (0.015mg/0.05ml) immediately after 
surgery and again 12 hours later for pain management. At least 4 days were allowed for 
recovery prior to the first behavior test. Pups were weighed daily after surgery, and 
cannulae were checked daily for integrity.  
 
 
 Drugs and Infusions. Recombinant murine IL-10 (American Research Products) 
was prepared in our laboratory, and both the IL-10 and vehicle solution were stored at  
-80˚ C until administration. For the central infusion, a pup was gently removed from its 
home cage one hour prior to the test. It was infused with 5 μl of either artificial 
cerebrospinal fluid (aCSF) or IL-10 in aCSF vehicle using a Hamilton Gas Tight 
syringe. Administration occurred slowly over the course of 2 minutes, and the tip 
remained in place for an additional 30 seconds to ensure full delivery and diffusion of the 
substance. After infusion, the pup was returned to the home cage for one hour prior to 
testing. To control for handling effects, on the second day of testing pups received no 
infusion but were handled for 2.5 minutes, one hour earlier, before being returned to their 
cages to await testing.  
 
Results 
  Passive behaviors. No significant effects of sex in either experimental condition 
were found; therefore, data were collapsed across sex. Overall, IL-10 tended to reduce 
each measure of passive behavior on each day (Figure 3). On Day 1, median levels of 
passive behaviors for pups of the IL-10 condition appeared lower than the median levels 
of passive behaviors for pups of the control condition. This difference was statistically 
  22 
reliable, however, only for piloerection (U=34.50, p<.05; 1-tailed test). A decrease in 
passive behaviors after IL-10 administration was expected, and replicated previous 
results by Perkeybile et al. (2009).  
 In terms of sensitization, passive behaviors were more frequent on Day 2 relative 
to Day 1; in the aCSF condition, all passive behaviors tended to increase on Day 2. Pups 
showed a greater number of intervals in crouch (p<.05), piloerection (p<.05), and the full 
passive response (p<.05) on the second separation, though no significant difference 
between days was noted for eye-close. In contrast, pups treated with IL-10 on Day 1 only 
showed an increase in piloerection (p<.05) on Day 2. 
 
 Active behaviors. A preliminary ANOVA with sex as a variable revealed no main 
or interaction effect. Therefore, data were subsequently analyzed with a 2-way Drug x 
Day ANOVA with Day treated as a repeated measure. No significant main or interaction 
effects for either variable (IL-10/aCSF or Day) were found for the active behavior of 

























Figure 3. Median number of 60-s intervals in which pups exhibited eye close, crouch, piloerection, and full 
passive response following administration of either aCSF or IL-10. IL-10 reduced levels of piloerection 
relative to pups treated with aCSF.  * differs from Day 1; p<0.05,  differs from aCSF Day 1; p<0.05, 1-


















































































































































































Mean levels (SE) of Active Behaviors of Guinea Pigs receiving aCSF and IL-10 
Measure Day 1 Day 2 
Vocalizations 
          aCSF 






           aCSF  












IV. Experiment 2 
 
Method 
 Two replications of 12 pups each (6 females and 6 males) were tested in this 
experiment. Each pup was unoperated and tested twice on consecutive days.    
 
Results 
 Passive behaviors. No effects of sex or replication were found for any measure on 
any day. Therefore, passive behavior scores were combined for both groups and across 
sex, and comparisons were made between Day 1 and Day 2 for all measures. Consecutive 
days of maternal separation sensitized passive behaviors of unoperated pups. Generally, 
the median levels of passive behaviors increased from Day 1 to Day 2 (Figure. 4). Pups 
showed significantly more eye-closure (p<.002) on Day 2 relative to Day 1, while crouch 
(p<.095) and the full passive response (p<.06) were marginally significant. No 
sensitization occurred for piloerection.  
 
 Active behaviors. In a preliminary analysis, there was no difference for sex or 
replication. There were no significant differences between days after combining the 











Figure. 4. Median number of intervals of eye-close, crouch, piloerection, and full passive response for 
unoperated pups. A significant difference was reported only for eye-close. * differs from Day 1; p<0.05. 
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V. General Discussion 
 
 
 It has become increasingly evident that pro-inflammatory cytokines can induce 
passive “sickness behaviors” in some species. These sickness behaviors are adaptive 
reactions that often occur during stress as well as direct activation of the immune system. 
The passive, not active, behaviors of isolated guinea pigs may be an example. The 
present study replicates the results of Hennessy et al. (2008) by showing that passive 
behaviors are greater during the second daily separation in guinea pig pups. It was 
hypothesized that the increase in behaviors from Day 1 to Day 2 may be due to a 
sensitization of the cytokine response. As such, we predicted that administration of an 
anti-inflammatory agent on the first isolation would reduce the increase of passive 
behaviors on the second.     
 On the first separation, the levels of passive behaviors tended to be lower in pups 
that received IL-10. These data are in agreement with previous findings by our laboratory 
that anti-inflammatory agents can significantly reduce passive behaviors (Perkeybile et 
al., 2009). The reductions in passive behaviors on Day 1 were not as robust as in the 
preceding experiment. These differences may be due to a smaller sample size, or analysis 
of between-subject comparisons in the present study rather than within-subject 
comparisons as in the previous experiment.  
 Although passive behaviors tended to increase between Day 1 and Day 2 in both 
aCSF and IL-10 groups, the effects were stronger for the aCSF condition. Three of the 
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four passive measures significantly increased in pups of the aCSF group, whereas only 
one of the four passive measures significantly increased in pups of the IL-10 group. 
Subjects that were given control vehicle exhibited significant increases in levels of 
crouch, piloerection, and full passive behavior on the second separation. An increase in 
the full passive response is of particular interest because it is the most stringent measure 
of passive behavior. Pups of the IL-10 condition demonstrated less sensitization, 
significant for one measure, than did pups of the aCSF condition. This supports our 
hypothesis that maternal isolation on Day 1 might increase the behavioral response on 
Day 2 by means of a pro-inflammatory mechanism. As predicted, the effect of an anti-
inflammatory agent was to produce less sensitization of passive behaviors.  
  Test subjects in the first experiment and in the previous study by Hennessy et al. 
(2008), all underwent surgical procedures that may have contributed to instances of 
passive behaviors. It is reasonable to believe that surgery could increase pro-
inflammatory activity, and might eventually influence the passive response and the 
ensuing behavioral sensitization. Therefore, we tested two replications of unoperated 
pups to see if sensitization occurred without the effects of surgery. Pups of this second 
experiment showed some evidence of sensitization, though it appeared to be weaker than 
that shown by aCSF pups. Further, on Day 1, pups that had undergone surgery and 
received vehicle control tended to show higher levels of passive behaviors (other than 
eye-close) than did pups of the unoperated condition. This suggests that an interaction 
exists whereby behavior is affected by experience, as well as the immune status of the 
pup at the time of the experience.  
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 It has not yet been determined which cytokines may be involved in the 
sensitization response. Given the eclectic bioactivity of various pro-inflammatory 
cytokines, there are numerous possibilities regarding the specific cytokine or groups of 
cytokines responsible for mediating sensitized behaviors. Previous studies have detected 
increases of TNF-α in the spleen of guinea pigs, but no increases were detected in central 
structures of the brain (Hennessy, Deak, Schiml-Webb & Barnum, 2007). IL-1 has been 
extensively studied as an effective promoter of cytokine-induced sickness behaviors in 
other rodent models. However, work to date with ELISA and RT-PCR procedures has 
failed to detect separation-induced changes in IL-1 or other pro-inflammatory markers in 
the brains of guinea pigs. Moreover, the present results do not address the specific targets 
of IL-10 that are involved in attenuating the passive response. IL-10 has long been known 
to suppress pro-inflammatory production in peripheral immune cells such as 
macrophages and dendritic cells, but central targets of IL-10 remain unclear. IL-10 may 
reduce pro-inflammatory cytokine expression in the hypothalamus and hippocampus, 
regions of the brain that are believed to have receptors for pro-inflammatory cytokines, 
and also possess the capability to mediate pro-inflammatory cytokine sickness behaviors 
(Maier & Watkins, 1998). 
 Evidence indicates that early stressors such as maternal separation can have 
permanent effects throughout adulthood. Various forms of attachment disruption can lead 
to increased risk for depression (Heim et al., 2008). There is also evidence indicating that 
an increased frequency of childhood illness may predispose an individual to adult 
depression. Key, Brown, Marsh, Spratt, and Recknor (2001) have found that adolescents 
with chronic illnesses reported nearly twice the occurrence of depressive symptoms 
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compared to control subjects. Especially male children, who suffered from ear infections, 
fever, and surgery, appeared to be at a higher risk for depression during the transition into 
adulthood (Reinherz, Giaconia, Carmola Hauf, Wasserman & Silverman, 1999). In 
essence, the overall well being of the child appeared to influence the onset of depressive 
symptoms after childhood (Raikkonen, Schubert, Pesonen, Heinonen, Viikari & 
Keltikangas-Jarvinen, 2004). Current literature suggests this might involve sensitization 
of neurochemical systems responsive to stress (e.g. CRF; Gillespie & Nemeroff, 2007). 
 Recent work with guinea pigs, including the present study, suggest that 
sensitization of cytokines may also provide a potential mechanism for the enduring 
effects of maternal separation. Avitsur and Sheridan (2009) recently found that neonatal 
maternal separation in rats could be a predisposing factor for the time and severity of 
LPS- or influenza virus-induced sickness behaviors. These findings also are in accord 
with the proposal that sensitization of cytokine systems can produce long-term effects. 
However, the present study provides some evidence for involvement of cytokines in 
behavioral sensitization over only a short 2-day period; implications for longer 
separations are speculative at this time. In sum, our results are consistent with the idea 
that sensitization may involve a pro-inflammatory effect. Future studies might examine 
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